Danimer Scientific Inc DNMR.N, DNMR.K is expected to show a fall in quarterly revenue when it reports results on November 19 for the period ending September 30 2024
The Bainbridge Georgia-based company is expected to report a 21.7% decrease in revenue to $8.575 million from $10.95 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.
LSEG's mean analyst estimate for Danimer Scientific Inc is for a loss of $8.13 per share.
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Danimer Scientific Inc is 40.00, above its last closing price of $8.81.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Jun. 30 2024 | -8.59 | -9.20 | -7.60 | Beat | 17.4 |
Mar. 31 2024 | -10.48 | -10.47 | -10.40 | Beat | 0.6 |
Dec. 31 2023 | -15.96 | -15.32 | -15.60 | Missed | -1.8 |
Sep. 30 2023 | -13.70 | -13.60 | -15.60 | Missed | -14.7 |
Jun. 30 2023 | -14.44 | -14.55 | -15.20 | Missed | -4.5 |
Mar. 31 2023 | -14.23 | -15.24 | -14.40 | Beat | 5.5 |
Dec. 31 2022 | -11.47 | -11.20 | Beat | 2.3 | |
Sep. 30 2022 | -6.90 | -7.01 | -37.60 | Missed | -436.4 |
This summary was machine generated November 15 at 13:34 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。